<DOC>
	<DOC>NCT00648310</DOC>
	<brief_summary>Despite the great number of reports about the efficacy of oestrogens or antimuscarinics on OAB symptoms, so far no author has tried to investigate whether the concomitant administration of these two drugs, acting on two different pathophysiological mechanisms, could have a synergic effect reducing the rate of non-responders to treatment.</brief_summary>
	<brief_title>Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>All postmenopausal women with symptoms of overactive bladder and urodynamically proven pure detrusor overactivity concomitant urodynamic stress incontinence documented recurrent urinary tract infections previous antimuscarinic treatment previous pelvic surgery concomitant systemic HRT history of breast or endometrial cancer neurological disease clinical contraindications to treatment with oestrogen or antimuscarinics patients included in other ongoing clinical trials</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>